NM
Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ
$1.04 -10.34% (-$0.12)
1M -39.88%
Market Cap $211.2M
P/E Ratio -
Div. Yield -
ROE 242.29%
Bulios Fair Price
$1.04
0.0% downside
Trenutna cena
$1.04
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica NMRA trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
41 /100
Fair P/B 4.74x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 216.08%
ROE 242.29%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.01x
Current ratio 4.50x
Int. coverage -32.09x
Stability
21 /100
Unstable Beta 2.74x
EPS volatility 43.21%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NMRA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Josh Pinto
Employees
63
Headquarters
Watertown
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report